Rampart Health
PrivateCompany Overview
Rampart Health is a biotechnology company that develops novel immunotherapy solutions for cancer treatment, including its Multiplex IntraTumoral Immunotherapy (MITI™) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
cancer immunotherapymultiplex intra-tumoral immunotherapyMITIpersonalized cancer vaccinetumor ablationabscopal effectmetastatic cancer treatmentclinical stage biotechimmuno-oncologysolid tumor therapybiotech R&Dprecision medicinedrug development
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rampart Health Comparables
Compare Rampart Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Syncromune, Inc. | 87% | |
| Lytix Biopharma AS | 79% | |
| Provectus Biopharmaceuticals | 78% | |
Rampart Health Funding Rounds
Historical fundraising activity
Rampart Health Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rampart Health's valuation, stock price, and market status.
See something wrong or outdated?